KRRO KORRO BIO INC revenue, earnings and financials
For the quarter ended June 30, 2026, KORRO BIO INC reported revenue of $0 (down 100.0% from a year earlier), net income of −$18.9M and diluted EPS of −$1.07; over the last four quarters revenue was $2.38M and net income −$107M; for the fiscal year ended December 2025 revenue was $6.39M, up 181.5% on the year before.
KRRO annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $6.39M, gross profit n/a, operating income −$122M, net income −$117M (margin -1834.5%), EPS −$12.48
- Fiscal year ended Dec 2024: revenue $2.27M, gross profit n/a, operating income −$91.9M, net income −$83.6M (margin -3680.4%), EPS −$9.37
- Fiscal year ended Dec 2023: revenue $0, gross profit n/a, operating income −$84.5M, net income −$81.2M (margin n/a), EPS −$53.08
- Fiscal year ended Dec 2022: revenue $0, gross profit n/a, operating income −$59.0M, net income −$58.0M (margin n/a), EPS −$227.42
- Fiscal year ended Dec 2021: revenue $14.1M, gross profit n/a, operating income −$84.0M, net income −$84.7M (margin -602.0%), EPS −$2.47
KRRO quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0 (down 100.0% year over year), net income −$18.9M, EPS −$1.07
- Quarter ended Mar 31, 2026: revenue $0 (down 100.0% year over year), net income −$19.6M, EPS −$1.69
- Quarter ended Dec 31, 2025 (from the annual report): revenue $1.29M (down 43.1% year over year), net income −$50.0M, EPS −$5.33
- Quarter ended Sep 30, 2025: revenue $1.09M, net income −$18.1M, EPS −$1.92
- Quarter ended Jun 30, 2025: revenue $1.46M, net income −$25.8M, EPS −$2.74
- Quarter ended Mar 31, 2025: revenue $2.55M, net income −$23.4M, EPS −$2.49
- Quarter ended Dec 31, 2024 (from the annual report): revenue $2.27M, net income −$21.2M, EPS −$2.24
- Quarter ended Sep 30, 2024: revenue $0, net income −$21.0M, EPS −$2.26
- Quarter ended Jun 30, 2024: revenue $0, net income −$21.8M, EPS −$2.43
- Quarter ended Mar 31, 2024: revenue $0, net income −$19.6M, EPS −$2.44
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$25.4M, EPS $148.03
- Quarter ended Sep 30, 2023: revenue n/a, net income −$18.5M, EPS −$65.08
- Quarter ended Jun 30, 2023: revenue n/a, net income −$17.6M, EPS −$63.83
- Quarter ended Mar 31, 2023: revenue n/a, net income −$19.6M, EPS −$72.20
- Quarter ended Dec 31, 2022 (from the annual report): revenue $0, net income $6.19M, EPS −$225.59
- Quarter ended Sep 30, 2022: revenue $0, net income −$19.5M, EPS −$0.55
- Quarter ended Jun 30, 2022: revenue $0 (down 100.0% year over year), net income −$21.3M, EPS −$0.61
- Quarter ended Mar 31, 2022: revenue $0 (down 100.0% year over year), net income −$23.4M, EPS −$0.67
- Quarter ended Dec 31, 2021 (from the annual report): revenue $0, net income −$21.5M, EPS −$0.62
- Quarter ended Sep 30, 2021: revenue $0, net income −$25.2M, EPS −$0.73
KRRO cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$78.6M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$60.1M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$67.3M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$53.6M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$76.1M, share buybacks n/a
KRRO balance sheet
- Jun 30, 2026: cash $24.9M, total assets $163M, total liabilities $60.2M, shareholders' equity n/a
- Mar 31, 2026: cash $61.7M, total assets $184M, total liabilities $64.0M, shareholders' equity n/a
- Dec 31, 2025: cash $21.8M, total assets $114M, total liabilities $62.1M, shareholders' equity n/a
- Sep 30, 2025: cash $24.2M, total assets $162M, total liabilities $62.5M, shareholders' equity n/a
- Jun 30, 2025: cash $33.6M, total assets $180M, total liabilities $65.3M, shareholders' equity n/a
- Mar 31, 2025: cash $64.1M, total assets $202M, total liabilities $63.3M, shareholders' equity n/a
- Dec 31, 2024: cash $55.6M, total assets $226M, total liabilities $65.8M, shareholders' equity n/a
- Sep 30, 2024: cash $63.2M, total assets $244M, total liabilities $63.9M, shareholders' equity n/a
What is KRRO's revenue?
KORRO BIO INC reported $2.38M of revenue over its last four quarters, through June 30, 2026.
Is KRRO profitable?
No. KORRO BIO INC lost $107M over the last four quarters.
What is KRRO's EPS?
Diluted earnings per share over the last four quarters were −$10.01; −$1.07 in the latest quarter.